Latest News
Feature
New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety Concerns
An FDA committee majority voted in support of a new drug-device combination that detects residual cancer, but some are not convinced the benefits...
Latest News
Drug Derived from LSD Granted FDA Breakthrough Status for Anxiety
Data from a phase 2b trial on LSD-based medication suggest a 48% remission rate in at 12 weeks in treatment of GAD.
Latest News
Sulfites Selected as ACDS Allergen of the Year
The exclusion of sulfites from most patch test series means that sulfite allergy diagnoses are often missed, despite the wide range of potential...
News from the FDA/CDC
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous Formulations
It’s unclear when the new tocilizumab products will be commercially available.
Conference Coverage
Leflunomide: A Fresh Look at an Old Drug
Overlooked in the biologic era, it still has a place.
Latest News
Medicare Pay Bump Provision in Federal Bill Falls Short, Doc Groups Say
The proposed boost in Medicare reimbursements for 2024 would only ease, but not fully reverse a 3.4% cut.
Conference Coverage
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
Latest News
Hospital Mergers in 2024: Five Things to Know
The outlook for mergers and acquisitions of hospitals this year includes increased concern regarding HCP and patient impact.
Latest News
Increased Risk of New Rheumatic Disease Follows COVID-19 Infection
While previous studies had identified a link between COVID-19 infection and greater risk of autoimmune disease, a new study is perhaps the largest...
Conference Coverage
Top Spondyloarthritis Studies of 2023 Include Underdiagnosis and Treatment in IBD
Besides the need to screen for spondyloarthritis more often in patients with inflammatory bowel disease, Dr. Eric Ruderman discussed finding the...